Ligand Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.About LGND
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world.
CEOTodd Christopher Davis
CEOTodd Christopher Davis
Employees68
Employees68
HeadquartersJupiter, Florida
HeadquartersJupiter, Florida
Founded1987
Founded1987
Employees68
Employees68
LGND Key Statistics
Market cap3.88B
Market cap3.88B
Price-Earnings ratio98.10
Price-Earnings ratio98.10
Dividend yield—
Dividend yield—
Average volume306.53K
Average volume306.53K
High today—
High today—
Low today—
Low today—
Open price$199.51
Open price$199.51
Volume0.00
Volume0.00
52 Week high$212.49
52 Week high$212.49
52 Week low$93.58
52 Week low$93.58
Stock Snapshot
Ligand Pharmaceuticals(LGND) stock is priced at $203.82, giving the company a market capitalization of 3.88B. It carries a P/E multiple of 98.10.
Ligand Pharmaceuticals(LGND) stock opened on 2026-01-23 at $199.51. The price climbed to — and dipped to —.
The Ligand Pharmaceuticals(LGND)'s current trading volume is 0, compared to an average daily volume of 306.53K.
During the past year, Ligand Pharmaceuticals(LGND) stock moved between $93.58 at its lowest and $212.49 at its peak.
During the past year, Ligand Pharmaceuticals(LGND) stock moved between $93.58 at its lowest and $212.49 at its peak.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.